Heat-resistant serum 4 type fowl adenovirus genetic engineering vaccine candidate strain and construction method thereof

A genetically engineered vaccine and avian adenovirus technology, applied in the field of genetically engineered vaccines, can solve the problems of loss of activity, loss of the ability to infect the host, and low tolerance.

Inactive Publication Date: 2019-12-24
YANGZHOU UNIV
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Generally speaking, NDV has low tolerance to heat, and it can be inactivated (losing the ability to infect the host) at 50-55°C for 30 minutes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Heat-resistant serum 4 type fowl adenovirus genetic engineering vaccine candidate strain and construction method thereof
  • Heat-resistant serum 4 type fowl adenovirus genetic engineering vaccine candidate strain and construction method thereof
  • Heat-resistant serum 4 type fowl adenovirus genetic engineering vaccine candidate strain and construction method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1: Serum type 4 poultry adenovirus genetic engineering vaccine strain construction

[0044] 1. Digestion of plasmid rVHR09-P

[0045] The transcription vector p-VHR09 containing the full-length genome of the attenuated NDV / rAHR09 mutant (GenBank: MF285077.1) was preserved by the Key Open Laboratory of Livestock and Poultry Infectious Diseases, Ministry of Agriculture, Yangzhou University (Cao Yongzhong et al. A thermostable gene Exogenous gene expression vector of type VIII attenuated Newcastle disease strain. Patent application number: CN201811244137.6, publication number: CN109295095A), see the plasmid map figure 1 . Use PmeI restriction endonuclease to carry out enzyme digestion and linearization in the intergenic region between P and M genes, and after the digestion product is subjected to 1% agarose gel electrophoresis, the linearized target fragment of about 18000bp is recovered, and the result is as follows figure 2 shown.

[0046] 2. Cloning and s...

Embodiment 2

[0067] Example 2: Identification of biological characteristics of recombinant virus

[0068] 1. Thermotolerance Determination of Recombinant Viruses

[0069] Take the 3rd generation allantoic fluid of the recombinant virus rAHR09-4F2, take 7 parts of 500 μL for each generation, put them in a metal bath at 56 ℃ for heat treatment, the heat treatment time is set to 20min, 30min, 40min, 50min, 60min, 70min, 80min, and carry out HA test. The results are shown in Table 1. The heat resistance test results show that rAHR09-4F2 still has HA activity after being treated at 56°C for 70 minutes.

[0070] Table 1 Determination results of heat-resistant hemagglutination activity of rAHR09-4F2 strain

[0071]

[0072] 2. EID of the recombinant virus 50 determination

[0073] The rAHR09-4F2 allantoic fluid was serially diluted 10 times, and 10 6 ~109 Doubly diluted virus, inoculate 9-11-day-old chicken embryos through the allantoic cavity, inoculate 5 eggs for each dilution of allant...

Embodiment 3

[0080] Embodiment 3: Recombinant virus rAHR09-4F2 immune efficacy test

[0081] 1. Experimental grouping and immunization

[0082] SPF chicken test groups are shown in Table 3. Vaccinations were performed when SPF chickens were 7 days old. The test chickens in the rAHR09-4F2 group were inoculated with rAHR09-4F2 (10 6 EID 50 ), the inactivated vaccine group was subcutaneously inoculated with FAdV-4+FAdV-8b bivalent inactivated vaccine (0.25mL / monkey) through the neck, and the challenge control group was inoculated with PBS (0.1mL / bird) through nasal drops. FAdV-4+FAdV-8b bivalent inactivated vaccine was prepared by referring to Hu Yage's method (Hu Yage. Development of bivalent oil emulsion inactivated vaccine of poultry group I adenovirus serotype 4 and 8b. Yangzhou University master's degree thesis, 2018.)

[0083] Table 3 Immunization test groups

[0084]

[0085] 2. Antibody level monitoring after immunization

[0086] On the 7th, 14th, 21st, and 28th day after th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a heat-resistant serum 4 type fowl adenovirus genetic engineering vaccine candidate strain and a construction method thereof. The candidate strain is a thermal-stability newcastle disease virus (Newcastle Disease Virus) rAHR09-4F2 expressing serum 4 type fowl adenovirus spike protein 2, and the preservation number is CCTCC NO: V201932. The candidate strain is obtained through using a heat-resistant newcastle disease attenuated virus strain rAHR09 as a carrier, inserting a serum 4 type fowl adenovirus (FAdV4) spike protein (fiber2) gene between a P intergenic region andan M intergenic region, and adopting a backward heredity technique. The result of evaluating the biological characteristics and the immunoprotection efficacy of the candidate strain displays that therecombinant virus has favorable heat stability and immunogenicity and provides favorable immunoprotection on FAdV4 infection.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering vaccines, and relates to a recombinant virus strain rAHR09-4F2 expressing the spike protein of serotype 4 avian adenovirus (FAdV-4) using heat-resistant Newcastle Disease Virus (Newcastle Disease Virus, NDV) as a carrier. The strain can be used to prevent and control poultry diseases caused by Group I avian adenovirus. Background technique [0002] Fowl adenovirus (Fowl adenovirus, FAdV) is an opportunistic pathogen that infects poultry, and generally does not show clinical symptoms, but under concurrent infection conditions, adenovirus can show severe pathogenicity. Group I avian adenoviruses can mainly cause diseases including avian hydropericardium syndrome (HPS), inclusion body hepatitis (IBH) and gizzard erosion (adenoviral gizzard erosion, AGH), among which the most serious damage is IBH and HPS. In recent years, group I adenoviruses of serotype 4 (FAdV-4) and serotype 8b (FAdV...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N7/01A61K39/235A61P31/20C12R1/93
CPCA61K39/12A61K2039/5256A61K2039/552A61P31/20C07K14/005C12N7/00C12N2710/10222C12N2710/10234C12N2760/18121
Inventor 吴艳涛李保珍曹永忠张小荣陈银郭梦娇张成成阮宝阳
Owner YANGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap